Fjarde Ap Fonden Biogen Inc. Transaction History

Fjarde Ap Fonden

$9.8 Billion
Q3 2024

A detailed history of Fjarde Ap Fonden transactions in Biogen Inc. stock. As of the latest transaction made, Fjarde Ap Fonden holds 31,721 shares of BIIB stock, worth $5.01 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

31,721

Previous 27,821 14.02%

Holding current value

$5.01 Million

Previous $6 Million 2.5%

% of portfolio

0.06%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$189.07 - $236.8 $737,373 - $923,520	3,900 Added 14.02%	31,721 $6.15 Million
Q1 2024 Apr 25, 2024	BUY	$212.02 - $267.71 $360,434 - $455,106	1,700 Added 6.51%	27,821 $6 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $22,259 - $26,794	100 Added 0.38%	26,121 $6.76 Million
Q3 2023 Oct 23, 2023	SELL	$253.3 - $285.89 $151,980 - $171,534	-600 Reduced 2.25%	26,021 $6.69 Million
Q2 2023 Aug 02, 2023	SELL	$275.25 - $318.06 $192,675 - $222,642	-700 Reduced 2.56%	26,621 $7.58 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $51,312 - $58,467	-200 Reduced 0.73%	27,321 $7.6 Million
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $1.19 Million - $1.44 Million	-4,700 Reduced 14.59%	27,521 $7.62 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $1.2 Million - $1.43 Million	-6,400 Reduced 16.57%	32,221 $6.57 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $794,457 - $1 Million	-4,100 Reduced 9.6%	38,621 $8.13 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $335,880 - $431,655	-1,500 Reduced 3.39%	42,721 $10.3 Million
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $198,093 - $258,335	-700 Reduced 1.56%	44,221 $12.5 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $802,900 - $1.29 Million	-3,100 Reduced 6.46%	44,921 $15.6 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $170,065 - $199,241	-700 Reduced 1.44%	48,021 $13.4 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $637,902 - $960,201	-2,700 Reduced 5.25%	48,721 $11.9 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $211,816 - $244,567	-800 Reduced 1.53%	51,421 $14.6 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $181,062 - $239,785	700 Added 1.36%	52,221 $14 Million
Q1 2020 May 11, 2020	SELL	$268.85 - $341.04 $457,045 - $579,768	-1,700 Reduced 3.19%	51,521 $16.3 Million
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $543,600 - $609,700	-2,500 Reduced 4.49%	53,221 $12.4 Million
Q2 2019 Jul 17, 2019	SELL	$219.29 - $241.72 $833,302 - $918,536	-3,800 Reduced 6.38%	55,721 $13 Million
Q1 2019 Apr 29, 2019	BUY	$216.71 - $338.96 $2.6 Million - $4.06 Million	11,982 Added 25.2%	59,521 $14.1 Million
Q4 2018 Jan 31, 2019	SELL	$278.5 - $352.75 $2.31 Million - $2.93 Million	-8,300 Reduced 14.86%	47,539 $14.3 Million
Q3 2018 Nov 09, 2018	SELL	$293.51 - $383.83 $928,665 - $1.21 Million	-3,164 Reduced 5.36%	55,839 $19.7 Million
Q2 2018 Jul 12, 2018	BUY	$257.52 - $306.91 $75,968 - $90,538	295 Added 0.5%	59,003 $17.1 Million
Q1 2018 May 07, 2018	BUY	$260.13 - $367.91 $30,695 - $43,413	118 Added 0.2%	58,708 $16.1 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $2.61 Million - $2.92 Million	8,480 Added 16.92%	58,590 $18.7 Million
Q3 2017 Nov 07, 2017	BUY	$281.15 - $329.69 $23,897 - $28,023	85 Added 0.17%	50,110 $15.7 Million
Q2 2017 Aug 08, 2017	BUY	N/A	50,025	50,025 $13.6 Million

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account